Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VRTX - VERTEX PHARMACEUTICALS INC / MA


IEX Last Trade
474.16
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:01:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 0.46%

PREVIOUS CLOSE
CHG
CHG%

$474.16
-78.66
0.20%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-10-28 2023-02-10 2023-05-02 2023-08-02 2023-11-07 2024-02-15 2024-05-07 2024-08-02
Total revenue 2.334 B 2.303 B 2.375 B 2.493 B 2.484 B 2.518 B 2.691 B 2.646 B
Cost of revenue 289.400 M 283.300 M 266.900 M 308.600 M 318.700 M 368.000 M 342.600 M 371.900 M
Gross profit 2.045 B 2.019 B 2.108 B 2.185 B 2.165 B 2.150 B 2.348 B 2.274 B
    -1.25% 4.38% 3.64% -0.91% -0.70% 9.22% -3.16%  
Operating expenses 891.800 M 959.500 M 983.700 M 1.048 B 1.074 B 1.194 B 1.132 B 1.339 B
Selling general and admin 246.800 M 267.400 M 241.100 M 262.600 M 263.800 M 369.100 M 342.700 M 372.200 M
Research and development 645.000 M 692.100 M 742.600 M 785.700 M 810.000 M 824.600 M 789.100 M 966.600 M
Total expenses 1.181 B 1.243 B 1.251 B 1.357 B 1.393 B 1.562 B 1.474 B 1.711 B
    5.22% 0.63% 8.50% 2.62% 12.15% -5.59% 16.03%  
Operating income 1.153 B 1.060 B 1.124 B 1.136 B 1.091 B 956.000 M 1.216 B 934.900 M
Ebit 1.153 B 1.060 B 1.124 B 1.136 B 1.091 B 956.000 M 1.216 B 934.900 M
Pretax income 1.176 B 1.077 B 891.500 M 1.162 B 1.179 B 1.148 B 1.279 B -3.391 B
    -8.47% -17.21% 30.29% 1.52% -2.68% 11.46% -365.12%  
Income tax 245.900 M 257.900 M 191.700 M 245.800 M 143.900 M 178.800 M 179.500 M 202.400 M
Net income basic 930.500 M 818.900 M 699.800 M 915.700 M 1.035 B 968.800 M 1.100 B -3.594 B
    -11.99% -14.54% 30.85% 13.06% -6.42% 13.50% -426.81%  
Net income 930.500 M 818.900 M 699.800 M 915.700 M 1.035 B 968.800 M 1.100 B -3.594 B
    -11.99% -14.54% 30.85% 13.06% -6.42% 13.50% -426.81%